SCARA5 suppresses the proliferation and migration, and promotes the apoptosis of human retinoblastoma cells by inhibiting the PI3K/AKT pathway

Wang,Jinwei; Wang,Sha; Chen,Lu; Tan,Jia

doi:10.3892/mmr.2021.11841

SCARA5 suppresses the proliferation and migration, and promotes the apoptosis of human retinoblastoma cells by inhibiting the PI3K/AKT pathway

Authors:
- Jinwei Wang
- Sha Wang
- Lu Chen
- Jia Tan
View Affiliations

Affiliations: Eye Center of Xiangya Hospital, Central South University, Changsha, Hunan 410008, P.R. China
Published online on: January 13, 2021 https://doi.org/10.3892/mmr.2021.11841
Article Number: 202
Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Retinoblastoma (RB) is the most common ocular malignancy that occurs during childhood. Scavenger receptor class A member 5 (SCARA5) is considered to function as an anti‑oncogene in several types of malignant tumor. The present study investigated the functional role and underlying mechanism of SCARA5 in human RB cells. Reverse transcription‑quantitative PCR and western blotting were used to detect the relative expression levels of SCARA5 in four human RB cell lines. In addition, transfection was performed to either knockdown or induce overexpression of SCARA5 in human RB Y79 cells. The proliferation, migration and apoptosis of RB cells was then measured by Cell Counting Kit 8 assay, 5‑ethynyl‑2'‑deoxyuridine assay, clone formation assay, Transwell assay, Hoechst staining and TUNEL staining, respectively. Western blotting was performed to detect changes in the expression levels of key proteins involved in the PI3K/AKT and apoptotic pathways. The present study revealed that SCARA5 was expressed at lower levels in four tumorigenic human RB cell lines compared with in a human retinal pigment non‑tumorigenic cell line. Functional analysis demonstrated that overexpression of SCARA5 decreased the proliferation and migration, and promoted the apoptosis of human RB cells in vitro, whereas in vivo experiments revealed a decrease in RB progression following SCARA5 overexpression. In addition, overexpression of SCARA5 inhibited phosphorylated (p)‑PI3K and p‑AKT expression, and knockdown of SCARA5 increased p‑PI3K and p‑AKT expression; however, no changes in total PI3K and AKT expression were observed. Bcl‑2 exhibited similar changes in expression to those displayed by p‑PI3K and p‑AKT, whereas Bax and cleaved caspase‑3 exhibited trends in expression that were the opposite to those shown by p‑PI3K and p‑AKT. In conclusion, the present results demonstrated that SCARA5 could inhibit the proliferation and promote the apoptosis of RB cell lines by suppressing the PI3K/AKT signaling pathway, thus suggesting a novel strategy for treating RB.

View Figures

View References

1	Gao Y and Lu X: Decreased expression of MEG3 contributes to retinoblastoma progression and affects retinoblastoma cell growth by regulating the activity of Wnt/β-catenin pathway. Tumour Biol. 37:1461–1469. 2016. View Article : Google Scholar : PubMed/NCBI
2	Chantada G and Schaiquevich P: Management of retinoblastoma in children: Current status. Paediatr Drugs. 17:185–198. 2015. View Article : Google Scholar : PubMed/NCBI
3	Zhou D, Liu P, Sun DW, Chen ZJ, Hu J, Peng SM and Liu YL: USP22 down-regulation facilitates human retinoblastoma cell aging and apoptosis via inhibiting TERT/P53 pathway. Eur Rev Med Pharmacol Sci. 21:2785–2792. 2017.PubMed/NCBI
4	Yang Q, Tripathy A, Yu W, Eberhart CG and Asnaghi L: Hypoxia inhibits growth, proliferation, and increases response to chemotherapy in retinoblastoma cells. Exp Eye Res. 162:48–61. 2017. View Article : Google Scholar : PubMed/NCBI
5	Shields CL and Shields JA: Retinoblastoma management: Advances in enucleation, intravenous chemoreduction, and intra-arterial chemotherapy. Curr Opin Ophthalmol. 21:203–212. 2010. View Article : Google Scholar : PubMed/NCBI
6	Shields CL and Shields JA: Basic understanding of current classification and management of retinoblastoma. Curr Opin Ophthalmol. 17:228–234. 2006. View Article : Google Scholar : PubMed/NCBI
7	Jabbour P, Chalouhi N, Tjoumakaris S, Gonzalez LF, Dumont AS, Chitale R, Rosenwasser R, Bianciotto CG and Shields C: Pearls and pitfalls of intraarterial chemotherapy for retinoblastoma. J Neurosurg Pediatr. 10:175–181. 2012. View Article : Google Scholar : PubMed/NCBI
8	Zhang H, Zhong J, Bian Z, Fang X, Peng Y and Hu Y: Long non-coding RNA CCAT1 promotes human retinoblastoma SO-RB50 and Y79 cells through negative regulation of miR-218-5p. Biomed Pharmacother. 87:683–691. 2017. View Article : Google Scholar : PubMed/NCBI
9	Lin P and O'Brien JM: Frontiers in the management of retinoblastoma. Am J Ophthalmol. 148:192–198. 2009. View Article : Google Scholar : PubMed/NCBI
10	Peiser L and Gordon S: The function of scavenger receptors expressed by macrophages and their role in the regulation of inflammation. Microbes Infect. 3:149–159. 2001. View Article : Google Scholar : PubMed/NCBI
11	Jiang Y, Oliver P, Davies KE and Platt N: Identification and characterization of murine SCARA5, a novel class A scavenger receptor that is expressed by populations of epithelial cells. J Biol Chem. 281:11834–11845. 2006. View Article : Google Scholar : PubMed/NCBI
12	Liu J, Hu G, Chen D, Gong AY, Soori GS, Dobleman TJ and Chen XM: Suppression of SCARA5 by Snail1 is essential for EMT-associated cell migration of A549 cells. Oncogenesis. 2:e732013. View Article : Google Scholar : PubMed/NCBI
13	Huang J, Zheng DL, Qin FS, Cheng N, Chen H, Wan BB, Wang YP, Xiao HS and Han ZG: Genetic and epigenetic silencing of SCARA5 may contribute to human hepatocellular carcinoma by activating FAK signaling. J Clin Invest. 120:223–241. 2010. View Article : Google Scholar : PubMed/NCBI
14	Xu Z, Hong Z, Ma M, Liu X, Chen L, Zheng C, Xi X and Shao J: Rock2 promotes RCC proliferation by decreasing SCARA5 expression through β-catenin/TCF4 signaling. Biochem Biophys Res Commun. 480:586–593. 2016. View Article : Google Scholar : PubMed/NCBI
15	Yan N, Zhang S, Yang Y, Cheng L, Li C, Dai L, Dai L, Zhang X, Fan P, Tian H, et al: Therapeutic upregulation of Class A scavenger receptor member 5 inhibits tumor growth and metastasis. Cancer Sci. 103:1631–1639. 2012. View Article : Google Scholar : PubMed/NCBI
16	Liu H, Hu J, Wei R, Zhou L, Pan H, Zhu H, Huang M, Luo J and Xu W: SPAG5 promotes hepatocellular carcinoma progression by downregulating SCARA5 through modifying β-catenin degradation. J Exp Clin Cancer Res. 37:2292018. View Article : Google Scholar : PubMed/NCBI
17	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
18	Onishi T, Matsuda S, Nakamura Y, Kuramoto J, Tsuruma A, Sakamoto S, Suzuki S, Fuchimoto D, Onishi A, Chikaki S, et al: Magnetically promoted rapid immunofluorescence staining for frozen tissue sections. J Histochem Cytochem. 67:575–587. 2019. View Article : Google Scholar : PubMed/NCBI
19	Thayanithy V, O'Hare P, Wong P, Zhao X, Steer CJ, Subramanian S and Lou E: A transwell assay that excludes exosomes for assessment of tunneling nanotube-mediated intercellular communication. Cell Commun Signal. 15:462017. View Article : Google Scholar : PubMed/NCBI
20	Hawkins P, Playle L, Golledge H, Leach M, Banzett R, Coenen A, Cooper J, Danneman P, Flecknell R, Kirkden R, et al: Newcastle consensus meeting on carbon dioxide euthanasia of laboratory animals. 1–17. 2006.
21	National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals, . Guide for the Care and Use of Laboratory Animals. 8th ed. National Academies Press (US); Washington (DC): 2011
22	Martini M, De Santis MC, Braccini L, Gulluni F and Hirsch E: PI3K/AKT signaling pathway and cancer: An updated review. Ann Med. 46:372–383. 2014. View Article : Google Scholar : PubMed/NCBI
23	Ancona-Lezama D, Dalvin LA and Shields CL: Modern treatment of retinoblastoma: A 2020 review. Indian J Ophthalmol. 68:2356–2365. 2020. View Article : Google Scholar : PubMed/NCBI
24	Rossukon K and Duangnate R: Retinoblastoma: Etiology, modeling, and treatment. Cancers (Basel). 12:23042020. View Article : Google Scholar
25	Sweid A, El Naamani K, Sajja KC, Hammoud B, Knapp MD, Moylan DD, Joffe D, Morse CE, Habbal D, Weinberg JH, et al: Incidence and predictors of ophthalmic artery occlusion in intra-arterial chemotherapy for retinoblastoma. J Neurointerv Surg. doi: http://dx.doi.org/10.1136/neurintsurg-2020-016759.
26	Chao H and Walsh CE: RNA repair for haemophilia A. Expert Rev Mol Med. 8:1–8. 2006. View Article : Google Scholar : PubMed/NCBI
27	Pluddemann A, Neyen C and Gordon S: Macrophage scavenger receptors and host-derived ligands. Methods. 43:207–217. 2007. View Article : Google Scholar : PubMed/NCBI
28	Peiser L, Mukhopadhyay S and Gordon S: Scavenger receptors in innate immunity. Curr Opin Immunol. 14:123–128. 2002. View Article : Google Scholar : PubMed/NCBI
29	Areschoug T and Gordon S: Scavenger receptors: Role in innate immunity and microbial pathogenesis. Cell Microbiol. 11:1160–1169. 2009. View Article : Google Scholar : PubMed/NCBI
30	Li JY, Paragas N, Ned RM, Qiu A, Viltard M, Leete T, Drexler IR, Chen X, Sanna-Cherchi S, Mohammed F, et al: Scara5 is a ferritin receptor mediating non-transferrin iron delivery. Dev Cell. 16:35–46. 2009. View Article : Google Scholar : PubMed/NCBI
31	Lee H, Lee YJ, Choi H, Seok JW, Yoon BK, Kim D, Han JY, Lee Y, Kim HJ and Kim JW: SCARA5 plays a critical role in the commitment of mesenchymal stem cells to adipogenesis. Sci Rep. 7:148332017. View Article : Google Scholar : PubMed/NCBI
32	De la Fuente IM and Lopez JI: Cell motility and cancer. Cancers (Basel). 12:21772020. View Article : Google Scholar
33	Kashyap S, Singh L, Kumar N, Singh MK, Pushker N, Bakhshi S, Sen S, Lomi N, Meel R and Chawla B: Combined association of massive choroidal and optic nerve invasion as a prognostic relevance in primary retinoblastoma: A 10-year study. Asia Pac J Clin Oncol. 2020.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
34	Bock AJ, Nymoen DA, Brenne K, Kaern J and Davidson B: SCARA3 mRNA is overexpressed in ovarian carcinoma compared with breast carcinoma effusions. Hum Pathol. 43:669–674. 2012. View Article : Google Scholar : PubMed/NCBI
35	Cao Y, Xia F, Wang P and Gao M: MicroRNA935p promotes the progression of human retinoblastoma by regulating the PTEN/PI3K/AKT signaling pathway. Mol Med Rep. 18:5807–5814. 2018.PubMed/NCBI
36	Fransecky L, Mochmann LH and Baldus CD: Outlook on PI3K/AKT/mTOR inhibition in acute leukemia. Mol Cell Ther. 3:22015. View Article : Google Scholar : PubMed/NCBI
37	Faes S and Dormond O: PI3K and AKT: Unfaithful partners in cancer. Int J Mol Sci. 16:21138–21152. 2015. View Article : Google Scholar : PubMed/NCBI
38	Follo MY, Manzoli L, Poli A, McCubrey JA and Cocco L: PLC and PI3K/Akt/mTOR signalling in disease and cancer. Adv Biol Regul. 57:10–16. 2015. View Article : Google Scholar : PubMed/NCBI
39	Ferenc P, Solar P, Kleban J, Mikes J and Fedorocko P: Down-regulation of Bcl-2 and Akt induced by combination of photoactivated hypericin and genistein in human breast cancer cells. J Photochem Photobiol B. 98:25–34. 2010. View Article : Google Scholar : PubMed/NCBI
40	Wu S, Ai N, Liu Q and Zhang J: MicroRNA448 inhibits the progression of retinoblastoma by directly targeting ROCK1 and regulating PI3K/AKT signalling pathway. Oncol Rep. 39:2402–2412. 2018.PubMed/NCBI
41	Xie C, Freeman MJ, Lu H, Wang X, Forster CL, Sarver AL and Hallstrom TC: Retinoblastoma cells activate the AKT pathway and are vulnerable to the PI3K/mTOR inhibitor NVP-BEZ235. Oncotarget. 8:38084–38098. 2017. View Article : Google Scholar : PubMed/NCBI
42	Meng B, Ii H, Qu W and Yuan H: Anticancer effects of gingerol in retinoblastoma cancer cells (RB355 Cell Line) are mediated via apoptosis induction, cell cycle arrest and upregulation of PI3K/Akt signaling pathway. Med Sci Monit. 24:1980–1987. 2018. View Article : Google Scholar : PubMed/NCBI